全球5岁以下与20岁以下镰状细胞贫血疾病负担的系统综述与荟萃分析
结果显示5岁以下患病率为0.008(95%CI 0.004-0.016),20岁以下为0.009(95%CI 0.005-0.017),20岁以下死因别死亡比例为0.029(95%CI 0.001-0.621)。作者指出儿童负担显著但异质性极大、不确定性宽、地理覆盖不全。
要点
- 5岁以下镰状细胞病患病率0.008(95%CI 0.004-0.016),20岁以下为0.009(95%CI 0.005-0.017)。
- 20岁以下死因别死亡比例为0.029(95%CI 0.001-0.621),5岁以下与5-19岁分别为0.021和0.017。
- 数据异质性与不确定性大,需加强筛查、监测与死因归因以准确估算负担。
核心结论
- 该首个针对5岁以下与20岁以下的全球合成分析显示儿科镰状细胞病负担可观,但受极端异质性、宽不确定性和地理覆盖不全限制。
- 作者强调亟需改进筛查、监测和死因归因,以支持镰状细胞病全球负担的准确估算。
研究设计与样本
- 系统综述与荟萃分析,检索2017至2023年发表的镰状细胞病患病率或死亡率研究。
- 采用随机效应荟萃分析生成合并估计,按年龄组、研究设计和联合国国家分组分类分层。
主要发现
- 5岁以下儿童患病率为0.008(95%CI 0.004-0.016)。
- 全球20岁以下人群患病率为0.009(95%CI 0.005-0.017)。
- 全球20岁以下死因别死亡比例为0.029(95%CI 0.001-0.621)。
- 5岁以下与5-19岁死亡比例分别为0.021和0.017。
临床怎么用
- 提示临床与公共卫生层面应关注5岁以下及20岁以下儿童的镰状细胞病筛查与早期识别。
- 结果可用于支持加强儿科死因登记与监测体系建设,但解读需考虑宽置信区间。
局限性
- 数据碎片化且诊断水平存在差异,地理覆盖不完整。
- 合并估计存在极端异质性与宽不确定性,限制结果的稳健解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sickle cell disease (SCD), a prevalent inherited non-communicable disease, remains a neglected public health priority, especially children and adolescents in many low- and middle-income countries. The global burden of SCD in youth remains under-characterized given fragmented data and disparities in diagnostics. This study aims to conduct a systematic review and meta-analysis quantifying the global prevalence and cause-specific mortality of SCD in individuals aged under-5 and under-20. A search was conducted to identify studies reporting SCD prevalence or mortality published between 2017 and 2023. Eligible studies were assessed for quality and random-effects meta-analyses generated pooled estimates, stratified by age group, study design and United Nations country group classification. Fifty-seven studies were included, encompassing data from over 3.6 million individuals and 56 593 recorded deaths. Among children under-5, the prevalence was 0.008 (95% confidence interval [CI]: 0.004-0.016). The global under-20 population-based prevalence of SCD was 0.009 (95% CI: 0.005-0.017). The global under-20 cause-specific mortality proportion was 0.029 (95% CI: 0.001-0.621), with under-5 and 5-19 years of age mortality proportions estimated at 0.021 and 0.017, respectively. This first global synthesis of under-5s and under-20s demonstrates substantial paediatric burden but is constrained by extreme heterogeneity, wide uncertainty and incomplete geographic coverage, underscoring the urgency for improved screening, surveillance and cause-of-death attribution to support accurate global burden estimation of SCD.
引用
- Pimenta K, Edwards J, Ray M, et al. Contemporary global burden of sickle cell anaemia under-5 and under-20: A systematic review and meta-analysis. Br J Haematol. 2026. PMID: 42070793. doi:10.1111/bjh.70501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。